Release Date: 24/12/18 11:40 Summary: Speedcast updates expectation for FY2018 Underlying EBITDA Price Sensitive: Yes Download Document 414.64KB Download
Webinar: What investors should know about what it takes for ASX-listed companies to get medical developments to market